3 Worth Considering Investments: ECare Solutions Inc.(ECSL), ImmunoCellular Therapeutics Ltd (IMUC) and InfuSystem Holdings Inc.(INFU)

Posted by admin February 17, 2015 0 Comment 1592 views

New York, NY – GDP INSIDER  –  02/17/2015.

This article discusses three companies: ECARE SOLUTIONS INC(OTCMKTS:ECSL), ImmunoCellular Therapeutics Ltd(NYSEMKTS:IMUC) and InfuSystem Holdings Inc.(NYSEMKTS:INFU).

ECARE SOLUTIONS INC(OTCMKTS:ECSL) was down 2.41% on Friday at $1.62  with a low trading volume of 27.5 thousand shares changing hands compared to its 3 month average of 110.6 thousand. The stock was riding high in January touching $2.42 but has fallen back into its regular trading range of between $1.50 and $2.00. ECare Solutions’ energy subsidiary, CyberFuels, is developing a new booster that is in the final testing phase and if successful could boost the company back over $2 and beyond making it a good long term investment prospect.

Why Is ECARE SOLUTIONS INC’s Stock Falling? See If This Can Boost Your Investment Income For The Year With Our Free ECSL Analysis.  

ImmunoCellular Therapeutics Ltd(NYSEMKTS:IMUC) is a biotechnology company focused on producing cutting edge drugs to fight cancer. ImmunoCellular currently has a promising drug in phase 3 testing and announced on Friday that it was issuing more stock to raise capital in order to complete the trials. The stock dropped 5.26% on the news of the share offering closing at $0.54. This is 6 cents below the $0.60 that the new shares are being offered at. With a 1 year target estimate of $3.50 and a potential new drug nearing completion, ImmunoCellular Therapeutics Ltd could reap dividends in the medium to long term.

What Does The Future Hold For ImmunoCellular Therapeutics Ltd? Click Here For Our Free IMUC Analysis To Find Out If It Can Make Your Portfolio Even Healthier.

InfuSystem Holdings Inc.(NYSEMKTS:INFU) is back within its regular trading range of $2.60 to $3.00 and closed on Friday up 0.37% at $2.72. Trading in the stock was very light with just under 15,000 shares trading, well below its 3 months average of 70,000.The infusion and healthcare service provider has been improving its results and with EPS now at 0.14 and a 1 year target estimate of $6.00, there is optimism that this stock may stage a rally later in the year as it did in November climbing to over $4. This stock is one to watch.

Will InfuSystem Holdings Inc Continue Gaining Momentum? Find All The Reasons Why This Stock Could Be The Infusion You Need With Our Free INFU Analysis.

About UltimateStockAlerts

UltimateStockAlerts.com provides investors and traders with trading strategies via text message and email. To obtain text message stock alerts service text the word ULTIMATE to 555888 from your cell phone.

UltimateStockAlerts continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.

Disclosure:  UltimateStockAlerts is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit www.UltimateStockAlerts.com website, for complete risks and disclosures.

Write Your Comment